PubMed=56444; DOI=10.1093/jnci/56.1.167
Golub S.H., Hanson D.C., Sulit H.L., Morton D.L., Pellegrino M.A., Ferrone S.
Comparison of histocompatibility antigens on cultured human tumor cells and fibroblasts by quantitative antibody absorption and sensitivity to cell-mediated cytotoxicity.
J. Natl. Cancer Inst. 56:167-170(1976)

PubMed=945229; DOI=10.1002/ijc.2910170408
Sulit H.L., Golub S.H., Irie R.F., Gupta R.K., Grooms G.A., Morton D.L.
Human tumor cells grown in fetal calf serum and human serum: influences on the tests for lymphocyte cytotoxicity, serum blocking and serum arming effects.
Int. J. Cancer 17:461-468(1976)

PubMed=954005
Zielske J.V., Golub S.H.
Fetal calf serum-induced blastogenic and cytotoxic responses of human lymphocytes.
Cancer Res. 36:3842-3846(1976)

PubMed=204583; DOI=10.1002/ijc.2910210308
Saxton R.E., Irie R.F., Ferrone S., Pellegrino M.A., Morton D.L.
Establishment of paired tumor cells and autologous virus-transformed cell lines to define humoral immune responses in melanoma and sarcoma patients.
Int. J. Cancer 21:299-306(1978)

PubMed=6500744; DOI=10.1002/ijc.2910340511
Ferrini U., Falcioni R., Delpino A., Cavaliere R., Zupi G., Natali P.G.
Heat-shock proteins produced by two human melanoma cell lines: absence of correlation with thermosensitivity.
Int. J. Cancer 34:651-655(1984)

Patent=US5840317
Morton D.L.
Composition comprising tumor cell lines containing GD2 ganglioside GM2 ganglioside, M-TAA, and either M-urinary antigen or M-fetal antigen.
Patent number US5840317, 24-Nov-1998

Patent=US5993828
Morton D.L.
Tumor associated antigen compositions and methods.
Patent number US5993828, 30-Nov-1999